Search Tag: Financial Report

2017 12 Jul

Hologic, Inc. has announced that the Company plans to release its financial results for the third quarter of fiscal 2017 on Wednesday, August 2, 2017, after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 877-780-3379...Read more

2017 15 May

Accelerate Diagnostics, Inc. announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $28.85 per share. The gross proceeds to Accelerate Diagnostics from the...Read more

2017 22 Apr

EOS imaging, pioneer in 2D/3D orthopaedic medical imaging, has announced the completion of a private placement in favour of domestic and international investors conducted by way of an accelerated book build offering. The Company has placed 1,868,000 new shares at a nominal value of €0.01, for a price of €4.20 each, issue premium included, which...Read more

2017 18 Jan

– EOS imaging, the pioneer in 2D/3D orthopaedic medical imaging, announces its consolidated revenue for the fourth quarter and full year ended December 31, 2016.     Marie Meynadier, CEO of EOS imaging, said: “In 2016 we delivered a strong year of execution of our growth strategy. At a commercial level, our teams and partners continued to drive...Read more

2016 03 Nov

- GAAP Diluted EPS of $0.33 Increases 266.7%, Non-GAAP Diluted EPS of $0.52 Increases 20.9% - - Revenue of $726.8 Million Grows 3.4%, 3.8% in Constant Currency - - In Fiscal 2017, Company Expects Mid-Single-Digit Revenue Growth, EPS Growth Roughly Double this Rate - Hologic, Inc. has announced the Company's financial results for the fiscal fourth...Read more

2016 04 Oct

Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued  November 23, 2010 , and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes. This conversion right is subject to the terms...Read more

2016 30 Sep

The Board of Directors of IT and medical technology company Sectra AB has decided to postpone the publication of the company’s six-month report for the May-October 2016 period until 8:00 a.m. on December 12, 2016.  The report was originally scheduled for publication on December 7, 2016. The decision to change the publication date was made to enable...Read more

2016 07 Sep

The Annual General Meeting (AGM) of shareholders in Sectra AB was held on September 6, 2016.  In accordance with a motion from the Board of Directors, the AGM resolved to transfer SEK 4.50 per share to shareholders through a redemption procedure. The resolution entails that approximately SEK 169.6 million will be distributed to shareholders....Read more

2016 09 May

Q1 2016 Highlights (compared to Q1 2015): Total revenue, including royalties, rose 10.8% to $171.2 million Product revenue rose 10.8% to $163.3 million Masimo rainbow® revenue rose 39.2% to $16.9 million SET® and rainbow® SET® units shipments were 46,300 GAAP net income of $27.6 million, or $0.53 per diluted share versus $20.5 million, or $0.38...Read more

2016 28 Apr

- GAAP Diluted EPS of $0.24 Increases 41.2%, Non-GAAP Diluted EPS of $0.47 Increases 14.6% - - Revenue of $693.3 Million Grows 5.8% on a Reported Basis, 6.3% in Constant Currency - - Company Redeploys $460.2 Million of Capital to Reduce Convertible Debt, and Repurchase Shares - Hologic, Inc. has announced the Company's financial results for...Read more

2016 26 Apr

The Board of Directors of Sectra AB has decided on the dates for the company’s financial reporting for the coming fiscal year. The following dates are planned for Sectra’s financial reporting: May 31, 2016: Year-end report 2015/2016 September 5, 2016: Three-month report September 6, 2016: Annual General Meeting in Linköping at 4:00 p.m. December...Read more

2016 01 Apr

Hologic, Inc. has announced that the Company plans to release its financial results for the second quarter of fiscal 2016 on Wednesday, April 27, 2016, after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.  Interested participants may listen to the call by dialing 888-455-2271...Read more

2016 07 Jan

Stable sales of equipment impacted by the last quarter Strong growth in North America EOS imaging (Paris:EOSI), the pioneer in 2D/3D orthopaedic medical imaging has announces its consolidated revenue for the fourth quarter and full year ended December 31, 2015. In millions of euros           2014       2013       &Read more

2016 05 Jan

Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2037 (CUSIP No. 436440 AB7) issued November 23, 2010, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes.  This conversion right is subject to the terms of...Read more

2015 22 Oct

246% growth in North America sales EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, announced its consolidated revenues for the third quarter and nine months ended September 30, 2015. € millions   Sept. 30, 2015 9 months   Sept 30, 2014 9 months       % change...Read more

2015 29 Jul

Comparable sales growth of 3% particularly driven by improvements in North America, Central & Eastern Europe and India EBITA, excluding restructuring and acquisition-related charges and other items, amounted to EUR 501 million, or 8.4% of sales, compared to 7.9% of sales in Q2 2014 EBITA totaled EUR 450 million, or 7.5% of sales, compared to...Read more